We show that VSV-IFNß treatment generated a highly significant expansion of one, or a few, dominant anti-viral effector CD8+ T cell populations with the concomitant relative disappearance of those putative anti-tumor T cell populations which are the target of anti-PD-L1 treatment. The gene discussed is IFNA1; the disease is neoplasm.